Cancer Res. 1999 Oct 1;59(19):4770-5.

Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy.

Hahnfeldt P, Panigrahy D, Folkman J, Hlatky L.

Source

Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

Abstract

The effects of the angiogenic inhibitors endostatin, angiostatin, and TNP-470 on tumor growth dynamics are experimentally and theoretically investigated. On the basis of the data, we pose a quantitative theory for tumor growth under angiogenic stimulator/inhibitor control that is both explanatory and clinically implementable. Our analysis offers a ranking of the relative effectiveness of these inhibitors. Additionally, it reveals the existence of an ultimate limitation to tumor size under angiogenic control, where opposing angiogenic stimuli come into dynamic balance, which can be modulated by antiangiogenic therapy. The competitive influences of angiogenically driven growth and inhibition underlying this framework may have ramifications for tissue size regulation in general.

PMID:: 10519381; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

HighWire Press

Other Literature Sources

COS Scholar Universe

Medical

Molecular Biology Databases

CYCLOHEXANE - HSDB

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Review Role of angiogenesis in tumor growth and metastasis. [Semin Oncol. 2002]
Review Role of angiogenesis in tumor growth and metastasis.
Folkman J. Semin Oncol. 2002 Dec; 29(6 Suppl 16):15-8.
The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors. [In Vivo. 2002]
The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M, Huang X, Zhu Z, Zhao Q, Wong M, Gorelik E. In Vivo. 2002 Nov-Dec; 16(6):577-82.
Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice. [Mol Ther. 2001]
Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Scappaticci FA, Smith R, Pathak A, Schloss D, Lum B, Cao Y, Johnson F, Engleman EG, Nolan GP. Mol Ther. 2001 Feb; 3(2):186-96.
Review Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy. [Endothelium. 2002]
Review Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.
Dell'Eva R, Pfeffer U, Indraccolo S, Albini A, Noonan D. Endothelium. 2002; 9(1):3-10.
Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. [Cancer Res. 2000]
Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
Yokoyama Y, Dhanabal M, Griffioen AW, Sukhatme VP, Ramakrishnan S. Cancer Res. 2000 Apr 15; 60(8):2190-6.

See reviews... See all...

Cited by 22 PubMed Central articles

Number and size distribution of colorectal adenomas under the multistage clonal expansion model of cancer. [PLoS Comput Biol. 2011]
Number and size distribution of colorectal adenomas under the multistage clonal expansion model of cancer.
Dewanji A, Jeon J, Meza R, Luebeck EG. PLoS Comput Biol. 2011 Oct; 7(10):e1002213. Epub 2011 Oct 13.
Mathematical model of the effect of interstitial fluid pressure on angiogenic behavior in solid tumors. [Comput Math Methods Med. 2011]
Mathematical model of the effect of interstitial fluid pressure on angiogenic behavior in solid tumors.
Phipps C, Kohandel M. Comput Math Methods Med. 2011; 2011:843765. Epub 2011 Sep 7.
Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy. [Int J Nanomedicine. 2011]
Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.
Lu ZX, Liu LT, Qi XR. Int J Nanomedicine. 2011; 6:1661-73. Epub 2011 Aug 11.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Tumor development under angiogenic signaling: a dynamical theory of tumor growth...
Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy.
Cancer Res. 1999 Oct 1 ;59(19):4770-5.

PubMed
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for ad...
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.
Cancer. 2003 Nov 1 ;98(9):1802-10.

PubMed
GATA-3 maintains the differentiation of the luminal cell fate in the mammary gla...
GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland.
Cell. 2006 Dec 1 ;127(5):1041-55.

PubMed
Systemic endocrine instigation of indolent tumor growth requires osteopontin.
Systemic endocrine instigation of indolent tumor growth requires osteopontin.
Cell. 2008 Jun 13 ;133(6):994-1005.

PubMed
High-fidelity mRNA amplification for gene profiling.
High-fidelity mRNA amplification for gene profiling.
Nat Biotechnol. 2000 Apr ;18(4):457-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: